Squawk on the Street
Stocks and Crypto Extend Slump, Exclusive With Take-Two CEO on Zynga Deal, and Gilead Sciences CEO on the Battle to Treat COVID
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Carl Quintanilla, Jim Cramer and David Faber explored how investors should navigate a rough start to the week for stocks: The tech sector extending its 2022 sell-off amid rising bond yields. Bitcoin and other cryptocurrencies also continuing to take a hit. Take-Two Interactive was the S&P 500's worst performer after the home of "Grand Theft Auto" announced it has agreed to acquire mobile gaming company Zynga for $9.86 per share in cash and stock, representing a 64% premium to Friday's closing price. Take-Two Chairman & CEO Strauss Zelnick appeared on the program exclusively to discuss the deal. As part of CNBC's coverage of the virtual J.P. Morgan Health Care Conference, Meg Tirrell interviewed Gilead Sciences CEO Daniel O'Day about his company's antiviral "Remdesivir" and how the treatment is faring against the COVID-19 omicron variant. Carl, Jim and David reacted to Wall Street firms' top stock picks for 2022. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.